Softgel Capsule Market Summary
As per Market Research Future analysis, the Softgel Capsule Market Size was estimated at 4.619 USD Billion in 2024. The Softgel Capsule industry is projected to grow from 4.882 USD Billion in 2025 to 8.499 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.7% during the forecast period 2025 - 2035
Key Market Trends & Highlights
The Softgel Capsule Market is experiencing robust growth driven by evolving consumer preferences and technological advancements.
- The demand for nutraceuticals continues to rise, particularly in North America, which remains the largest market for softgel capsules.
- Technological innovations in production are enhancing the efficiency and quality of softgel manufacturing, appealing to both nutraceutical and pharmaceutical segments.
- There is a notable shift towards plant-based ingredients, with vegetable gelatin emerging as the fastest-growing segment in the Asia-Pacific region.
- Increasing health awareness and the expansion of e-commerce platforms are key drivers propelling market growth, particularly in the nutraceutical sector.
Market Size & Forecast
| 2024 Market Size | 4.619 (USD Billion) |
| 2035 Market Size | 8.499 (USD Billion) |
| CAGR (2025 - 2035) | 5.7% |
Major Players
Catalent (US), Amway (US), BASF (DE), FMC Corporation (US), Lonza (CH), Soft Gel Technologies (US), Ginkgo BioWorks (US), Natural Alternatives International (US), Aenova Group (DE), EuroCaps (GB)